KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Current Assets (2016 - 2025)

Historic Current Assets for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $47.6 billion.

  • Merck's Current Assets rose 1782.91% to $47.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $47.6 billion, marking a year-over-year increase of 1782.91%. This contributed to the annual value of $38.8 billion for FY2024, which is 2056.08% up from last year.
  • Latest data reveals that Merck reported Current Assets of $47.6 billion as of Q3 2025, which was up 1782.91% from $37.1 billion recorded in Q2 2025.
  • In the past 5 years, Merck's Current Assets ranged from a high of $47.6 billion in Q3 2025 and a low of $26.9 billion during Q1 2021
  • In the last 5 years, Merck's Current Assets had a median value of $32.2 billion in 2023 and averaged $34.0 billion.
  • In the last 5 years, Merck's Current Assets tumbled by 994.91% in 2023 and then soared by 2744.77% in 2024.
  • Over the past 5 years, Merck's Current Assets (Quarter) stood at $30.3 billion in 2021, then increased by 18.03% to $35.7 billion in 2022, then dropped by 9.95% to $32.2 billion in 2023, then rose by 20.56% to $38.8 billion in 2024, then rose by 22.63% to $47.6 billion in 2025.
  • Its Current Assets was $47.6 billion in Q3 2025, compared to $37.1 billion in Q2 2025 and $35.5 billion in Q1 2025.